London, UK – GHO Capital, the European specialist investor in healthcare, acknowledges the announcement from its portfolio company Envision Pharma Group regarding its acquisition of Touch Creative Design Limited, a UK-based Pharma/Healthcare focused agency with multi-industry experience.
To underpin their commitment to clients to provide pioneering scientific multichannel medical communication solutions alongside their purpose built industry-leading software, Envision are delighted to announce the acquisition of Touch Creative Design Agency (Touch).
The Touch team brings a wealth of experience, creativity, and an impressive portfolio of innovative projects within the healthcare arena. Touch will collaborate with Envision to deliver significant creative and digital capabilities to extend Envision’s ever-expanding multichannel offering. Bringing the organisations together will also give the agency extended reach and investment to support new initiatives.
Envision’s Chief Strategy Officer, David Thompson, commented: “We are thrilled to welcome Touch to the Envision family. The addition of Touch to the group augments our existing capabilities and further cements our core principle of marrying scientific expertise and technology. Touch’s cutting-edge ideas, skills, and experience enhances our multichannel offering and ensures clients continue to receive best-in-class Medical Affairs solutions.”
Touch Managing Director, Vonig Watson, stated: “For 13 years Touch has established itself as a talented Pharma/Healthcare Creative Communications Agency, with innovation, reliability, and creativity at its core. It is with great pleasure that Touch has now become part of Envision enabling our combined multichannel communications expertise to be extended to a wider audience and, ultimately, to benefit more patients worldwide. Together we aim to raise the bar in delivering full-service Pharma/Healthcare multichannel communications for our clients.”